VECURONIUM BROMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for vecuronium bromide and what is the scope of patent protection?
Vecuronium bromide
is the generic ingredient in two branded drugs marketed by Organon Usa Inc, Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for vecuronium bromide. Nine suppliers are listed for this compound.
Summary for VECURONIUM BROMIDE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 10 |
| NDAs: | 13 |
| Drug Master File Entries: | 5 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 12 |
| Patent Applications: | 2,781 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in VECURONIUM BROMIDE? | VECURONIUM BROMIDE excipients list |
| DailyMed Link: | VECURONIUM BROMIDE at DailyMed |
Recent Clinical Trials for VECURONIUM BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University | Phase 4 |
| Guangdong Provincial People's Hospital | Phase 4 |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
Pharmacology for VECURONIUM BROMIDE
| Drug Class | Nondepolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for VECURONIUM BROMIDE
US Patents and Regulatory Information for VECURONIUM BROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 075549-002 | Jun 13, 2000 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sun Pharm | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 079001-002 | Jun 17, 2009 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sun Pharm | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 079001-001 | Jun 17, 2009 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Watson Labs | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 074334-001 | Aug 31, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Gland | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 205390-001 | May 26, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hikma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 203725-002 | Jul 30, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VECURONIUM BROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
| Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-003 | Jan 3, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
| Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-003 | Jan 3, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
| Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
| Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
